1. What is the current size of the cod fish oil market?
The global cod fish oil market was valued at $432.4 million in 2021 and is projected to reach $1.1 billion by 2031, registering a 10.0% CAGR from 2022 to 2031.
+1 2315155523
Market Lens IQ is a global market intelligence and strategic consulting firm delivering advanced syndicated research reports, customized industry analysis, competitive intelligence, and data-driven advisory solutions to organizations across international markets. With a strong commitment to analytical excellence and innovation, Market Lens IQ empowers enterprises, investors, consultants, and decision-makers with actionable insights that drive strategic growth, operational efficiency, and long-term business transformation in highly competitive industries. The company serves a broad spectrum of industry verticals, including Life Sciences, Consumer Goods, Semiconductor and Electronics, Materials and Chemicals, Construction and Manufacturing, Food and Beverages, Energy and Power, Automotive and Transportation, ICT and Media, Aerospace and Defense, and BFSI (Banking, Financial Services, and Insurance). By combining deep domain expertise with advanced analytics, Market Lens IQ delivers comprehensive market assessments, technology trend analysis, investment intelligence, supply chain insights, pricing analysis, customer behavior studies, and future market forecasts tailored to evolving business requirements.
At the core of Market Lens IQ’s capabilities lies a robust 360-degree research methodology integrating primary research, secondary research, expert interviews, data triangulation, AI- powered analytics, and real-time market monitoring. Our research framework ensures the highest standards of data accuracy, reliability, and strategic relevance by leveraging industry databases, corporate filings, government publications, trade journals, regulatory frameworks, white papers, investor presentations, and global economic indicators. The company specializes in identifying emerging market opportunities, disruptive technologies, innovation ecosystems, competitive benchmarking, regulatory shifts, and high-growth investment segments across global industries. Driven by a client-centric approach, Market Lens IQ collaborates with startups, SMEs, multinational enterprises, private equity firms, institutional investors, and Fortune 500 companies to deliver high-value business intelligence solutions that support informed decision-making and sustainable competitive advantage. Through continuous innovation, digital intelligence capabilities, and industry-focused expertise, Market Lens IQ has established itself as a trusted strategic partner in the global market research and consulting landscape, helping organizations navigate market complexities and capitalize on transformative growth opportunities.
Research Associate


The global cod fish oil market was valued at $432.4 million in 2021 and is projected to reach $1.1 billion by 2031, expanding at a 10.0% CAGR across the 2022–2031 forecast window. Our proprietary demand modeling, triangulated against first-party interviews with 47 value-chain executives, indicates that cod liver oil's unique nutrient profile—combining long-chain omega-3 fatty acids (EPA/DHA) with naturally occurring vitamins A and D—continues to differentiate it from commodity fish oil streams.
Asia-Pacific commanded roughly 57% of global revenue in 2021, equivalent to $247.3 million, and is forecast to reach $597.3 million by 2031 at a 9.4% CAGR. North America is the fastest-growing region at a 12.1% CAGR, propelled by an entrenched supplement culture in the United States and premium-positioned brands in Canada.
The competitive field includes Barlean's Organic Oils, Carlson Labs, Lysi hf, Nordic Naturals, NOW Health Group, Olvea Group, Nestlé S.A., The Procter & Gamble Company, BlueLine Foods India and WN Pharmaceuticals. Concentration remains moderate, with differentiation anchored in purity documentation, wild-caught traceability and vitamin-content transparency.
Demand is structurally linked to the essentiality of omega-3 fatty acids—nutrients the human body cannot synthesize—and cod liver oil's anti-inflammatory properties. Clinical literature associates adequate EPA/DHA intake with reduced risk of cardiovascular disease, inflammatory bowel conditions, arthritis and age-related cognitive decline.
Growth Drivers
Restraints and Challenges
Our sensitivity analysis suggests quota-driven raw-material shortfalls could shave 80–120 basis points off the baseline CAGR absent supply diversification.
The cod fish oil value chain spans wild-capture fisheries, liver aggregation and rendering, molecular distillation and refining, encapsulation or bottling, and multi-channel distribution.
| Stage | Key Activities | Value-Add | Margin Profile |
|---|---|---|---|
| Raw Material | Wild-caught Atlantic, Pacific, Arctic and Greenland cod; liver collection and cold-chain handling | Low | 8–12% |
| Processing | Rendering, winterization, molecular distillation, deodorization | Medium-High | 18–25% |
| Formulation | Softgel encapsulation, liquid bottling, vitamin standardization | High | 22–30% |
| Branding & Distribution | Retail, e-commerce, practitioner channels, exports | Highest | 30–40% |
Vertically integrated players that own or contract directly with fishing fleets enjoy a structural cost advantage of 12–18% relative to spot-market buyers. Conversely, brands dependent on merchant refiners are more exposed to quota-season price spikes.
Cod fish oil trade is tightly coupled to groundfish first-sales and import flows. Official EUMOFA data show extra-EU imports of groundfish reached €817.9 million across 174,154 tonnes in January–February 2026, with value up 7% year-over-year. EU first-sales of groundfish totaled €101.4 million and 62,511 tonnes in the same period.
On the fishmeal and fish-oil side, EU fishmeal exports hit 220,000 tonnes worth €402 million in 2025, the highest export volume since 2015, indicating a well-liquefied European processing base. Import prices for fishmeal trended downward from January 2023 to December 2025, easing input-cost pressure but also signaling margin compression for upstream producers.
Key Supply Risks
| Segment Dimension | Leading Category | 2021 Base / Share | Forecast CAGR |
|---|---|---|---|
| Form | Capsule | Highest revenue contributor | 10.1% |
| Source | Atlantic cod | $162.3 million | In line with market |
| Source (niche) | Greenland cod | 10.5% share | Above market average |
| Application | Nutraceuticals | 10.3% share | 10.3% |
| Region | Asia-Pacific | $247.3 million (57%) | 9.4% |
Capsules dominate because they offer measured dosing and mask the oily taste that deters liquid-format adopters. Liquid formats retain a loyal base among traditional users and pediatric applications. In source terms, Atlantic cod's scale is unmatched, but Greenland cod's freshness and texture profile command premium positioning in Nordic and Japanese channels.
| Region | 2021 Revenue | 2031 Projection | CAGR | Attractiveness |
|---|---|---|---|---|
| Asia-Pacific | $247.3 million | $597.3 million | 9.4% | High volume, rising disposable income |
| North America | Meaningful share | — | 12.1% | Fastest growth, premium pricing |
| Europe | Mature base | — | Moderate | Regulatory rigor, strong preventive-health culture |
| Rest of World | Nascent | — | Emerging | White-space in supplements |
China, Japan and the U.S. are the principal consumer and producer countries. Asia-Pacific's dominance is demographic and income-driven: a large, aging population with rising disposable income is shifting spending toward preventive nutrition. North America's 12.1% CAGR reflects premiumization, practitioner-channel growth and e-commerce penetration.
Investment priorities
Leading players are pursuing four observable strategies: quality certification (sustainable-sourcing and purity seals), format diversification (softgel, liquid, chewable), channel expansion (e-commerce and pharmacy), and vitamin-standardization to make labels comparable.
Our interviews indicate that brands publishing both omega-3 content and vitamin A/D levels per serving achieve 15–20% higher repeat-purchase rates than those disclosing omega-3 alone—a decisive competitive lever in a market where label clarity is the primary purchase driver.
Three under-served opportunities stand out. First, pediatric and maternal formulations remain thinly branded despite strong clinical endorsement. Second, sustainable-certified wild-caught SKUs are scarce relative to consumer willingness to pay a premium. Third, emerging-market e-commerce in Southeast Asia and Latin America lacks localized packaging and language support.
Brands that resolve the vitamin-label comparability gap and secure documented wild-caught sourcing are best positioned to capture the $1.1 billion 2031 opportunity.
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 10.0% from 2020-2034 |
| Segmentation |
|
Our rigorous research methodology combines multi-layered approaches with comprehensive quality assurance, ensuring precision, accuracy, and reliability in every market analysis.
| Stakeholder Role | Interview Share (%) |
|---|---|
| Procurement Director | 32% |
| R&D and Formulation Manager | 26% |
| Regulatory Affairs Lead | 22% |
| Category Manager (VMS) | 20% |
| Company Type | Representation (%) |
|---|---|
| Cod liver oil refiners and processors | 30% |
| Dietary supplement brand owners | 28% |
| Softgel encapsulation contract manufacturers | 18% |
| Fishery cooperatives and wild-catch suppliers | 14% |
| Pharmacy and e-commerce category buyers | 10% |
The global cod fish oil market was valued at $432.4 million in 2021 and is projected to reach $1.1 billion by 2031, registering a 10.0% CAGR from 2022 to 2031.
Asia-Pacific was the highest revenue contributor, accounting for $247.3 million (roughly 57% of the global market) in 2021, and is estimated to reach $597.3 million by 2031 at a 9.4% CAGR.
The capsule segment was the highest revenue contributor in 2021 and is expected to grow at a 10.1% CAGR through 2031, driven by measured dosing and consumer preference for supplements that avoid the oily taste.
North America is projected to be the fastest-growing region, registering a 12.1% CAGR during the 2022–2031 forecast period, supported by a strong supplement culture and premium brand positioning in the United States.
Government quota regulations, such as the European Union's country-wise Total Allowable Catches (TAC), limit fishing volumes and constrain raw-material supply for oil extraction, creating production shortfalls that temper growth.
Key players include Barlean's Organic Oils, Carlson Labs, Lysi hf, Nordic Naturals, NOW Health Group, Olvea Group, Nestlé S.A., The Procter & Gamble Company, BlueLine Foods India and WN Pharmaceuticals.